These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

613 related articles for article (PubMed ID: 11712810)

  • 41. Proinflammatory interferon-gamma--inducing monokines (interleukin-12, interleukin-18, interleukin-15)--serum profile in patients with systemic lupus erythematosus.
    Robak E; Robak T; Wozniacka A; Zak-Prelich M; Sysa-Jedrzejowska A; Stepien H
    Eur Cytokine Netw; 2002; 13(3):364-8. PubMed ID: 12231481
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clinical significance of nailfold capillaroscopy in systemic lupus erythematosus: correlation with endothelial cell activation markers and disease activity.
    Kuryliszyn-Moskal A; Ciolkiewicz M; Klimiuk PA; Sierakowski S
    Scand J Rheumatol; 2009; 38(1):38-45. PubMed ID: 18991188
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Expression of high mobility group box chromosomal protein 1 and its modulating effects on downstream cytokines in systemic lupus erythematosus.
    Li J; Xie H; Wen T; Liu H; Zhu W; Chen X
    J Rheumatol; 2010 Apr; 37(4):766-75. PubMed ID: 20110525
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Alpha-actinin-binding antibodies in relation to systemic lupus erythematosus and lupus nephritis.
    Becker-Merok A; Kalaaji M; Haugbro K; Nikolaisen C; Nilsen K; Rekvig OP; Nossent JC
    Arthritis Res Ther; 2006; 8(6):R162. PubMed ID: 17062137
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Elevated gene expression of Th1/Th2 associated transcription factors is correlated with disease activity in patients with systemic lupus erythematosus.
    Lit LC; Wong CK; Li EK; Tam LS; Lam CW; Lo YM
    J Rheumatol; 2007 Jan; 34(1):89-96. PubMed ID: 17117487
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Soluble cytokinin receptors in renal vasculitis and lupus nephritis].
    Tesar V; Jirsa M; Masek Z; Bartůnková J; Stejskalová A; Dostál C; Zabka J; Chábová V; Rysavá R
    Cas Lek Cesk; 1998 May; 137(9):271-5. PubMed ID: 9650355
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Subclinical disease activity in systemic lupus erythematosus: immunoinflammatory markers do not normalize in clinical remission.
    Wais T; Fierz W; Stoll T; Villiger PM
    J Rheumatol; 2003 Oct; 30(10):2133-9. PubMed ID: 14528506
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Systemic levels of the T cell regulatory cytokines IL-10 and IL-12 in Bechçet's disease; soluble TNFR-75 as a biological marker of disease activity.
    Turan B; Gallati H; Erdi H; Gürler A; Michel BA; Villiger PM
    J Rheumatol; 1997 Jan; 24(1):128-32. PubMed ID: 9002023
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Relationship between peripheral blood dendritic cells and cytokines involved in the pathogenesis of systemic lupus erythematosus.
    Robak E; Smolewski P; Wozniacka A; Sysa-Jedrzejowska A; Stepień H; Robak T
    Eur Cytokine Netw; 2004; 15(3):222-30. PubMed ID: 15542447
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The reduction of serum B-lymphocyte activating factor levels following quinacrine add-on therapy in systemic lupus erythematosus.
    Toubi E; Kessel A; Rosner I; Rozenbaum M; Paran D; Shoenfeld Y
    Scand J Immunol; 2006 Apr; 63(4):299-303. PubMed ID: 16623930
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Serum soluble interleukin-2 receptor alpha in systemic lupus erythematosus.
    El-Shafey EM; El-Nagar GF; El-Bendary AS; Sabry AA; Selim AG
    Iran J Kidney Dis; 2008 Apr; 2(2):80-5. PubMed ID: 19377213
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pregnancy, cytokines, and disease activity in systemic lupus erythematosus.
    Doria A; Ghirardello A; Iaccarino L; Zampieri S; Punzi L; Tarricone E; Ruffatti A; Sulli A; Sarzi-Puttini PC; Gambari PF; Cutolo M
    Arthritis Rheum; 2004 Dec; 51(6):989-95. PubMed ID: 15593367
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Increased serum levels of immunoglobulins, C-reactive protein, type 1 and type 2 cytokines in patients with mixed connective tissue disease.
    Bakri Hassan A; Rönnelid J; Gunnarsson I; Karlsson G; Berg L; Lundberg I
    J Autoimmun; 1998 Oct; 11(5):503-8. PubMed ID: 9802936
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Elevation of plasma osteopontin concentration is correlated with disease activity in patients with systemic lupus erythematosus.
    Wong CK; Lit LC; Tam LS; Li EK; Lam CW
    Rheumatology (Oxford); 2005 May; 44(5):602-6. PubMed ID: 15705633
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Serum levels of tumour necrosis factor family members a proliferation-inducing ligand (APRIL) and B lymphocyte stimulator (BLyS) are inversely correlated in systemic lupus erythematosus.
    Morel J; Roubille C; Planelles L; Rocha C; Fernandez L; Lukas C; Hahne M; Combe B
    Ann Rheum Dis; 2009 Jun; 68(6):997-1002. PubMed ID: 18676986
    [TBL] [Abstract][Full Text] [Related]  

  • 56. IL-15 and IL-15R in leucocytes from patients with systemic lupus erythematosus.
    Baranda L; de la Fuente H; Layseca-Espinosa E; Portales-Pérez D; Niño-Moreno P; Valencia-Pacheco G; Abud-Mendoza C; Alcocer-Varela J; González-Amaro R
    Rheumatology (Oxford); 2005 Dec; 44(12):1507-13. PubMed ID: 16251219
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Raised levels of interleukin 6 in systemic lupus erythematosus correlate with anaemia.
    Ripley BJ; Goncalves B; Isenberg DA; Latchman DS; Rahman A
    Ann Rheum Dis; 2005 Jun; 64(6):849-53. PubMed ID: 15897306
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Increased levels of serum protein oxidation and correlation with disease activity in systemic lupus erythematosus.
    Morgan PE; Sturgess AD; Davies MJ
    Arthritis Rheum; 2005 Jul; 52(7):2069-79. PubMed ID: 15986354
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Reduced anti-TNFalpha autoantibody levels coincide with flare in systemic lupus erythematosus.
    Sjöwall C; Ernerudh J; Bengtsson AA; Sturfelt G; Skogh T
    J Autoimmun; 2004 Jun; 22(4):315-23. PubMed ID: 15120755
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Levels of soluble Fas/APO-1 in patients with Behçet's disease.
    Hamzaoui K; Hamzaoui A; Zakraoui L; Chabbou A
    Mediators Inflamm; 1998; 7(2):111-4. PubMed ID: 9836498
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.